Town & Country Bank & Trust CO dba First Bankers Trust CO Buys 4,124 Shares of Stryker Corporation $SYK

Town & Country Bank & Trust CO dba First Bankers Trust CO lifted its position in Stryker Corporation (NYSE:SYK) by 40.9% during the 4th quarter, Holdings Channel reports. The firm owned 14,213 shares of the medical technology company’s stock after buying an additional 4,124 shares during the quarter. Stryker makes up 1.7% of Town & Country Bank & Trust CO dba First Bankers Trust CO’s investment portfolio, making the stock its 15th biggest holding. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Stryker were worth $4,995,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Clayton Financial Group LLC bought a new stake in Stryker during the third quarter worth about $26,000. Howard Hughes Medical Institute bought a new position in shares of Stryker in the second quarter valued at approximately $29,000. United Financial Planning Group LLC acquired a new position in shares of Stryker in the 3rd quarter worth approximately $27,000. Strive Asset Management LLC bought a new stake in Stryker during the 3rd quarter worth approximately $30,000. Finally, ANTIPODES PARTNERS Ltd bought a new position in Stryker in the 3rd quarter valued at $34,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. William Blair restated an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Piper Sandler reissued an “overweight” rating on shares of Stryker in a report on Tuesday, January 27th. Barclays restated an “overweight” rating and issued a $469.00 price objective on shares of Stryker in a research report on Monday, February 2nd. Truist Financial dropped their target price on shares of Stryker from $400.00 to $392.00 and set a “hold” rating for the company in a research note on Thursday, December 18th. Finally, Evercore set a $390.00 price target on shares of Stryker in a research note on Monday, January 5th. Fourteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $427.50.

Stryker Trading Down 0.0%

Shares of SYK opened at $331.48 on Friday. The stock’s fifty day simple moving average is $357.10 and its 200-day simple moving average is $361.86. The firm has a market capitalization of $126.95 billion, a PE ratio of 39.46, a price-to-earnings-growth ratio of 1.94 and a beta of 0.92. Stryker Corporation has a 12-month low of $319.32 and a 12-month high of $404.87. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last released its earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. The company had revenue of $7.17 billion for the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The company’s revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the company posted $4.01 EPS. As a group, research analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker’s payout ratio is currently 41.90%.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. The trade was a 9.23% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 5.90% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.